Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition DomainLekha Mikkilineni, James N. Kochenderfer, Norris Lam et al.|Blood|2020Cited by 20
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domainLekha Mikkilineni, James N. Kochenderfer, Danielle Natrakul et al.|Molecular Therapy|2023Cited by 16
Treatment of Patients with T Cells Expressing a Fully-Human Anti-BCMA CAR with a Heavy-Chain Antigen-Recognition Domain Caused High Rates of Sustained Complete Responses and Relatively Mild ToxicityLekha Mikkilineni, James N. Kochenderfer, Elisabet E. Manasanch et al.|Blood|2021Cited by 9
T Cells Expressing a Fully-Human Anti-BCMA Chimeric Antigen Receptor with a Heavy-Chain-Only Antigen-Recognition Domain Exhibit Rapid and Durable Activity Against Multiple MyelomaLekha Mikkilineni, James N. Kochenderfer, Elisabet E. Manasanch et al.|Blood|2022Cited by 7